SCHEMBL26294115

SCHEMBL26294115

c1ccc(-c2cc3c(cc2-c2ccccc2)C2(c4ccccc4-c4ccc(-c5ccc(-c6nc7ccccc7n6-c6ccccc6)cc5)cc42)c2ccccc2-3)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.47
ESR2 Q92731 2/20 0.47
RECQL P46063 1/20 0.42
GRIA1 P42261 1/20 0.41
CACNG8 Q8WXS5 1/20 0.41
CACNG2 Q9Y698 1/20 0.41
HDAC1 Q13547 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
PTGS2 P35354 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
HSP90AA1 P07900 1/20 0.37
MAPT P10636 1/20 0.37
RAB9A P51151 1/20 0.37
PRKACA P17612 1/20 0.37
RPS6KB1 P23443 1/20 0.37
GSK3B P49841 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12121655 0.95 ESR1 (0.48) ESR1ESR2RECQLGRIA1CACNG8
SCHEMBL24648300 0.93 ESR1 (0.50) ESR1ESR2RECQLGRIA1CACNG8
SCHEMBL21402178 0.93 ESR1 (0.50) ESR1ESR2RECQLGRIA1CACNG8
SCHEMBL19164151 0.91 ESR2 (0.54) ESR1ESR2RECQLGRIA1CACNG8
SCHEMBL11954080 0.89 ESR1 (0.46) ESR1ESR2RECQLGRIA1CACNG8
SCHEMBL13562930 0.89 ESR1 (0.48) ESR1ESR2RECQLGRIA1CACNG8
SCHEMBL17470584 0.88 ESR1 (0.46) ESR1ESR2RECQLGRIA1CACNG8
SCHEMBL13784059 0.88 ESR1 (0.46) ESR1ESR2RECQLGRIA1CACNG8
SCHEMBL13784122 0.88 ESR1 (0.46) ESR1ESR2RECQLGRIA1CACNG8
SCHEMBL20173193 0.88 ESR1 (0.44) ESR1ESR2RECQLGRIA1CACNG8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234937-A1 INDENOAZANAPHTHALENES MERCK PATENT GMBH (DE) 2023-07-27 US disclosed
US-20230234937-A1 INDENOAZANAPHTHALENES MERCK PATENT GMBH (DE) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234937-A1 INDENOAZANAPHTHALENES NQO1, CYP2D6, SQOR ESR1 205/4885ESR2 712/4885RECQL 521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.